Atlas Trials

Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial

Clinical trial NCT04049097 · TERMINATED

Trial details

NCT number
NCT04049097
Sponsor
ZevraDenmark
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Inclusion Body Myositis
Start date
2019-05-20
Primary completion
2021-11-15
Enrollment
121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.